ArticleBMJ open2019
Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- How Did Zero-Markup Medicines Policy Change Prescriptions in the Eyes of Patients?-A Retrospective Quasi-Experimental Analysis.International journal of environmental research and public health · 2022Pooled it
- Provider and patient perceptions of traditional Chinese medicine service pricing reform: evidence from Northeast China.Frontiers in public health · 2026Article
- The impact of national comprehensive medical reform on healthcare quality: evidence from China.Frontiers in public health · 2026Article
- Selective strategic adaptation and structural trade-offs in a public traditional Chinese medicine hospital under China's national performance appraisal: a longitudinal study.Frontiers in health services · 2026Article
- Did China's hospital reforms improve curative care expenditures? Evidence from Beijing hospitals.BMC health services research · 2025Article
- The universal zero markup drug policy and gastric cancer hospitalization expenses: an analysis of trends and influencing factors in Shanghai from 2014 to 2021.BMC health services research · 2025Article
- Utilization of upper gastrointestinal tumor inpatient services affected by COVID-19 in China 2018-2021: an interrupted time series analysis.Frontiers in public health · 2025Article
- The work relative value estimation assessment in China: an empirical research for common surgical procedures.Frontiers in public health · 2024Article
- Costs of traditional Chinese medicine treatment for inpatients with lung cancer in China: a national study.BMC complementary medicine and therapies · 2023Article
- Hospital crowdedness evaluation and in-hospital resource allocation based on image recognition technology.Scientific reports · 2023Article
- Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis.Frontiers in public health · 2023Article
- Clinical features and direct medical cost of splenic injury in China: a cross-sectional study.BMJ open · 2022Article
- Medical Service Utilization and Direct Medical Cost of Stroke in Urban China.International journal of health policy and management · 2022Article
- Article
- Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China.Frontiers in pharmacology · 2022Article
- The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study.Frontiers in medicine · 2022Article
- Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China.BMC health services research · 2021Article
- Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China.Cancer medicine · 2021Article
- Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study.Evidence-based complementary and alternative medicine : eCAM · 2021Article
- Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China.International journal for equity in health · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the 2017 implementation of China's 2009 healthcare price reforms on Beijing's secondary and tertiary traditional Chinese medicine (TCM) hospitals.
designWe employed a panel-interrupted time-series model with hospital fixed effects to estimate the impact of the price reforms.
settingBeijing, April 2014 to April 2018.
participantsAll TCM hospitals in Beijing. OUTCOME MEASURES: Our dependent variables comprised the monthly outpatient and inpatient revenues, the number of monthly outpatient visits and inpatient admissions, the average total expenditures per outpatient visit and per inpatient admission, the average drug expenditures (except herbal medicines) per outpatient visit and per inpatient admission and the average medical service expenditures per outpatient visit and per inpatient admission.
resultsIn tertiary hospitals, the price reforms led to significant reductions in the number of outpatient visits (23.1%), inpatients admission (4.6%) and drug expenditures (except herbal medicines) per inpatient admission (14.0%), and an instant raise in average total expenditure per outpatient (22.0%), medical service expenditures per outpatient visit (58.2%) and inpatient admission (19.0%). There was no significant association between the price reforms and the monthly outpatient and inpatient revenues. After the price reforms, the previous upward trend in medical service expenditures per outpatient visit rose more sharply (from 0.5% to 1.6%). In secondary hospitals, the price reforms decreased the level of drug expenditures (except herbal medicines) per outpatient visit (13.0%) and per inpatient admission (20.8%), but increased medical service expenditures per inpatient admission by 19.0%.
conclusionThe Beijing price reforms adjusted the cost structures in secondary and tertiary TCM hospitals without negatively impacting the operation of the hospitals, and through the increased hierarchical medical service fee, shifted patient choices away from tertiary to other health facilities, especially for patients with minor illnesses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.